NITRIC OXIDE

Course overview

NITRIC OXIDE IS A MEDICATION USED TO MANAGE AND TREAT HYPOXIC RESPIRATORY FAILURE OR PERSISTENT PULMONARY HYPERTENSION IN NEWBORNS. IT IS IN THE MISCELLANEOUS RESPIRATORY AGENT CLASS OF DRUGS. ITS ADMINISTRATION IN THE CLINICAL SCENARIO AS AN INHALANT (INO) FOR ADJUNCTIVE RESCUE THERAPY AND IMPROVED OXYGENATION OF PERSISTENT PULMONARY HYPERTENSION OF NEWBORNS (PPHN) AND ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS). OFF LABELED, IT IS USED TO TREAT ACUTE BRONCHIOLITIS AND AS RESCUE THERAPY IN PATIENTS WITH COVID-19 AND SEVERE ARDS AFTER OTHER ALTERNATIVES HAVE FAILED. THIS ACTIVITY DESCRIBES THE INDICATIONS, MECHANISM OF ACTION, AND CONTRAINDICATIONS FOR NITRIC OXIDE AS A VALUABLE AGENT IN TREATING PPHN. IN ADDITION, THIS ACTIVITY WILL HIGHLIGHT THE ADVERSE EFFECTS, ADMINISTRATION, AND OTHER KEY FACTORS PERTINENT TO INTERPROFESSIONAL TEAM MEMBERS IN TREATING NEONATAL PATIENTS WITH PPHN.